Mood and anxiety disorder patients reported both benefits and worsening from cannabis, rarely consulting doctors
Among 36 patients with mood or anxiety disorders who used cannabis, most continued for symptom coping despite acknowledging cognitive dysfunction and worsening mood with ongoing use, and few consulted medical professionals.
Quick Facts
What This Study Found
Cannabis use was initiated from curiosity, peer pressure, or treatment dissatisfaction. Continuation was driven by psychotropic effects and symptom coping (mood, insomnia). Over time, users acknowledged negative effects including cognitive dysfunction, worsening mood, and increased anxiety. Concerning patterns included initiation before age 18, mixed medical/recreational use, and rare medical consultation.
Key Numbers
36 patients interviewed. All had mood or anxiety disorder diagnoses. Many initiated use before age 18. Mixed medical and recreational use common. Medical professional consultation was rare.
How They Did This
Qualitative study with 36 adults diagnosed with mood or anxiety disorders (including OCD and PTSD) who currently use cannabis. In-depth interviews explored motivations, perceptions, effects, and patterns of cannabis use. Thematic analysis applied.
Why This Research Matters
The disconnect between perceived and actual effects is clinically important. Patients reported continuing cannabis for symptom relief even as they recognized it was making things worse, highlighting the complexity of self-medication in mental health populations.
The Bigger Picture
With cannabis legalization increasing access, mental health patients are self-treating at growing rates. The finding that patients recognize harm but continue using underscores the need for proactive clinician engagement rather than waiting for patients to raise the topic.
What This Study Doesn't Tell Us
Small qualitative sample from a single setting. Self-selected cannabis-using patients may not represent non-users with the same diagnoses. Canadian context with legal access may differ from other jurisdictions. Qualitative design captures experiences but not prevalence.
Questions This Raises
- ?What specific cannabis products or dosing patterns are associated with worsening versus improvement?
- ?Would structured clinician conversations change patients cannabis use patterns?
- ?Could specific cannabis products (e.g., CBD-dominant) avoid the mood-worsening effects patients reported?
Trust & Context
- Key Stat:
- Patients recognized harm but continued using for symptom relief
- Evidence Grade:
- Qualitative study providing rich experiential data. Evidence grading does not apply, but the consistent themes across 36 participants add credibility.
- Study Age:
- Published in 2024 in Pharmacopsychiatry.
- Original Title:
- Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.
- Published In:
- Pharmacopsychiatry, 57(3), 141-151 (2024)
- Authors:
- Das, Ankita, Hendershot, Christian S(6), Husain, M Ishrat, Knyahnytska, Yuliya, Elsaid, Sonja, Le Foll, Bernard, Kloiber, Stefan
- Database ID:
- RTHC-05249
Evidence Hierarchy
Uses interviews or focus groups to understand experiences in depth.
What do these levels mean? →Frequently Asked Questions
Does cannabis help people with anxiety and depression?
Patients in this study initially found cannabis helpful for mood and sleep. However, with continued use, many recognized negative effects including worse mood, increased anxiety, and cognitive problems, yet continued using.
Do mental health patients talk to their doctors about cannabis?
Rarely, according to this study. Despite using cannabis to manage diagnosed conditions, patients seldom consulted medical professionals about their use, potential effects, or possible harms.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-05249APA
Das, Ankita; Hendershot, Christian S; Husain, M Ishrat; Knyahnytska, Yuliya; Elsaid, Sonja; Le Foll, Bernard; Kloiber, Stefan. (2024). Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.. Pharmacopsychiatry, 57(3), 141-151. https://doi.org/10.1055/a-2264-1047
MLA
Das, Ankita, et al. "Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.." Pharmacopsychiatry, 2024. https://doi.org/10.1055/a-2264-1047
RethinkTHC
RethinkTHC Research Database. "Perceptions, Experiences, and Patterns of Cannabis Use in In..." RTHC-05249. Retrieved from https://rethinkthc.com/research/das-2024-perceptions-experiences-and-patterns
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.